The states with the highest Medicaid prescribing rates for the anti-craving drug buprenorphine — Vermont, West Virginia, Kentucky, Montana and Ohio — all expanded the program.
Published: August 21, 2019 at 02:00AM
from NYT Health https://ift.tt/2KWib7g